Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 17,78117,800 of 20,252 grants

Completed OTHER RESEARCH-RELATED
Targeting the Stroma for Pancreatic Cancer Treatment
NATIONAL CANCER INSTITUTE Cedars-Sinai Medical Center United States 2021 – 2026

PROJECT SUMMARY Pancreatic ductal adenocarcinoma (PDAC) remains one of the deadliest malignancies despite the recent paradigm shifting success of immunotherapy noted in many other...

$2.44M
USD
Completed OTHER RESEARCH-RELATED
Dietary Regulation of Colon Cancer Metastasis
NATIONAL CANCER INSTITUTE Massachusetts Institute of Technology United States 2021 – 2025

Project Summary/AbstractColorectal cancer (CRC) is the third most frequent cancer worldwide with increasing incidences every year. It is the leading cause of cancer related mortali...

$938.1K
USD
Completed NON-SBIR/STTR RPGS
Targeting Checkpoint Inhibition in Anti-Tumor Responses
NATIONAL CANCER INSTITUTE Sanford Burnham Prebys Medical Discovery... United States 2021 – 2023

PROJECT SUMMARY The goal of this project is to evaluate novel therapeutics that block PSGL-1 (P-selectin glycoprotein-1), which we identified as a key inhibitory receptor (IR) that...

$975K
USD
Completed TRAINING, INDIVIDUAL
Targeting purine biosynthesis to radiosensitize glioblastoma
NATIONAL CANCER INSTITUTE University of Michigan At Ann Arbor United States 2021 – 2024

Project Summary/Abstract Glioblastoma (GBM) is the most common aggressive primary brain tumor and is uniformly fatal with a median survival of around 1.5-years. Like surgery and ch...

$697.7K
USD
Completed NON-SBIR/STTR RPGS
Radiomics and Pathomics to predict upstaging of DCIS
NATIONAL CANCER INSTITUTE H. Lee Moffitt Cancer Ctr & Res Inst United States 2021 – 2026

Abstract Ductal carcinomas in situ (DCIS) of the breast are a heterogeneous group of neoplastic lesions that are usually detected by screening mammography. Workup generally include...

$6.69M
USD
Completed NON-SBIR/STTR RPGS
Origins and functions of pancreatic cancer-associated fibroblasts
NATIONAL CANCER INSTITUTE Oregon Health & Science University United States 2021 – 2022

PROJECT SUMMARY/ABSTRACT The mechanisms underlying evolution of tumor-associated stroma remain poorly understood. In solid tumors featuring a prominent stromal reaction, an improve...

$852.2K
USD
Completed NON-SBIR/STTR RPGS
Integrated visualization, control, and analysis of GEF – GTPase networks in living cells
NATIONAL CANCER INSTITUTE Ut Southwestern Medical Center United States 2021 – 2026

A small number of Rho family GTPases participate in a broad array of fundamental cellular behaviors. Specificity is possible due to spatial and temporal control of GTPase “activati...

$5.15M
USD
Completed NON-SBIR/STTR RPGS
Repurposing Leflunomide to Delay Progression of Smoldering Multiple Myeloma in African Americans
NATIONAL CANCER INSTITUTE Beckman Research Institute/City of Hope United States 2021 – 2026

PROJECT SUMMARY Smoldering multiple myeloma (SMM) is an asymptomatic precursor of active multiple myeloma (MM), and 50 percent of patients meeting criteria for high-risk disease wi...

$6.57M
USD
Completed NON-SBIR/STTR RPGS
Applying deep learning to predict T cell receptor binding specificity of neoantigens and response to checkpoint inhibitors
NATIONAL CANCER INSTITUTE Ut Southwestern Medical Center United States 2021 – 2025

Project Summary Background: In-depth study of neoantigens will promote our knowledge of the fundamental mechanisms of basic immunology and immune-related disease processes, such as...

$3.6M
USD
Completed TRAINING, INDIVIDUAL
Understanding the Role of Macrophages and Iron in the Tumor Microenvironment
NATIONAL CANCER INSTITUTE Pennsylvania State University Hershey Me... United States 2021 – 2023

PROJECT SUMMARY/ABSTRACT Glioblastoma is one of the most aggressive and hard to treat human cancers facing modern medicine. The current standard of care for a new diagnosis of glio...

$517.5K
USD
Completed NON-SBIR/STTR RPGS
Role of RABL6A-PP2A in neuroendocrine tumors
NATIONAL CANCER INSTITUTE University of Iowa United States 2021 – 2026

Project Summary / Abstract Neuroendocrine tumors (NETs) are incurable, clinically challenging malignancies that are rising in incidence. Although tumors grow slowly, they progress...

$5.23M
USD
Completed NON-SBIR/STTR RPGS
Mechanisms of the BRCA-network in tumorigenesis and therapeutic response
NATIONAL CANCER INSTITUTE Rbhs -Cancer Institute of New Jersey United States 2021 – 2023

Mechanisms of the BRCA-network in Tumorigenesis and Therapeutic Response (OVERALL) Abstract: The faithful repair of DNA damage and efficient resolution of stalled replication forks...

$22.7M
USD
Completed NON-SBIR/STTR RPGS
Project 1: Recruitment of the BRCA1-associated Homologous Recombination Machinery
NATIONAL CANCER INSTITUTE Rbhs -Cancer Institute of New Jersey United States 2021 – 2023

PROJECT SUMMARY: “RECRUITMENT OF THE BRCA1-ASSOCIATED HOMOLOGOUS RECOMBINATION MACHINERY” A substantial proportion of tumors show patterns of mutation that arise because of problem...

Completed NON-SBIR/STTR RPGS
Project 2: Targeting DNA replication in BRCA-associated breast cancer
NATIONAL CANCER INSTITUTE Rbhs -Cancer Institute of New Jersey United States 2021 – 2023

PROJECT SUMMARY Germline mutations in BRCA1 and BRCA2 and PALB2 predispose to breast cancer and also increase the risks of ovarian, pancreatic, prostate, and other cancers. The pro...

Completed NON-SBIR/STTR RPGS
Core 1: Mouse and Cell Modeling
NATIONAL CANCER INSTITUTE Rbhs -Cancer Institute of New Jersey United States 2021 – 2023

PROJECT SUMMARY (Core-1) Genetically engineered cell lines and mouse models are critical for elucidating complex biological processes. The ability to customize the context in which...

Completed NON-SBIR/STTR RPGS
Core 2: Genomics
NATIONAL CANCER INSTITUTE Rbhs -Cancer Institute of New Jersey United States 2021 – 2023

ABSTRACT The Genomics Core (Core 2) will provide support with genomics profiling and integrative bioinformatics analysis support for all the four projects, contributing towards the...

Completed NON-SBIR/STTR RPGS
Role of ALDH in PARP inhibitor resistance in HR-deficient ovarian cancer
NATIONAL CANCER INSTITUTE Ohio State University United States 2021 – 2026

Summary Poly (ADP-ribose) polymerase (PARP) inhibitors (PARPi) are an exciting and promising new class of anticancer drugs, which have been approved by the FDA for recurrent ovaria...

$3.4M
USD
Completed NON-SBIR/STTR RPGS
Multiethnic GWAS and TWAS to Inform Risk Prediction for Prostate Cancer
NATIONAL CANCER INSTITUTE University of Southern California United States 2021 – 2026

Abstract Prostate cancer (PCa) incidence is highest in African Americans and lowest in Asians. These long-standing racial/ethnic differences have yet to be explained. Genome-wide a...

$6.16M
USD
Completed NON-SBIR/STTR RPGS
Project 2: Targeting DNA replication in BRCA-associated breast cancer
NATIONAL CANCER INSTITUTE Rbhs -Cancer Institute of New Jersey United States 2021 – 2026

PROJECT SUMMARY Germline mutations in BRCA1 and BRCA2 and PALB2 predispose to breast cancer and also increase the risks of ovarian, pancreatic, prostate, and other cancers.The prod...

Completed NON-SBIR/STTR RPGS
Project 3: Chromatin modifiers of BRCA-related DNA repair Pathways
NATIONAL CANCER INSTITUTE Rbhs -Cancer Institute of New Jersey United States 2021 – 2026

PROJECT SUMMARY/ABSTRACT: Induction of a DNA break initiates DNA damage signaling pathways that lead to coordinated and dynamic modification of the local chromatin landscape, inclu...